Diacetazotol inhibits dioxin-induced ethoxyresorufin-O-deethylase ( EROD ) activity with IC 50 of 75±4 nM. Diacetazotol extracts from patent US20070032458, compound 3.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Cytochrome P450
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.